Our Studies

To date, we have successfully completed over 500 FDA-approved studies in the areas of allergy, asthma and immunological diseases. At any given time, we are running numerous studies, advancing the frontiers of research and the possibilities of treatments every day.

CURRENT STUDIES

To apply to participate in one of our studies, please go here. If you would like to participate in a specific study, please note that when you fill out our survey.

ENGAGE – Eosinophilic Gastritis (EoG) Study

Study Treatment: Dupixent Injection
Subjects: Adults and children over 12 with EoG

For full information go to this link in clinicaltrials.gov

Contact mnelsen@seattleallergy.org if interested in participating

Interested in Participating in a Study?

If you are eligible you will be contacted by one our research coordinators.

VITESSE – Patch Study in Peanut Allergic Children

Study Treatment: DBV712 – Peanut Patch
Subjects: Peanut allergic children aged 4-7

For full information go to this link in clinicaltrials.gov

Contact tderovanessian@seattleallergy.org if interested in participating

NATRON – Hypereosinophilic Syndrome (HES)

Study Treatment: Benralizumab – monoclonal antibody injection
Subjects: People over 12 with HES

For full information go to this link in clinicaltrials.gov

Contact lmiller@seattleallergy.org if interested in participating

More Studies Coming Soon!

Fill out our survey to be contacted for future clinical research trials at our site

Novartis – One-month Study for Peanut Allergic Adults

Study Treatment: Oral Remibrutinib
Subjects: Peanut allergic adults aged 18-55

For full information go to this link in clinicaltrials.gov

Contact jfernandez@seattleallergy.org if interested in participating

REMIX KIDS – Chronic Spontaneous Urticaria (CSU) Hives Study

Study Treatment: Oral Remibrutinib
Subjects: Children aged from 12-18 with CSU 

For full information go to this link in clinicaltrials.gov

Contact akunze@seattleallergy.org if interested in participating

More Studies Coming Soon!

Fill out our survey to be contacted for future clinical research trials at our site

NIMBLE – Eosinophilic Asthma Comparison Study

Study Treatment: Depemokimab compared with mepolizumab or benralizumab
Subjects: Adults and children over 12 with eosinophilic asthma currently taking mepolizumab or benralizumab

For full information go to this link in clinicaltrials.gov

Contact jfernandez@seattleallergy.org if interested in participating

ONGOING STUDIES
(NO FURTHER ENROLLMENT)

  • Alladapt ENCORE

  • Siolta ADORED STMC-103H-102

  • AstraZeneca MANDARA

  • DBV EPOPEX (EPITOPE Extension)

  • Novartis REMIX-2 CSU

  • Novartis REMIX Open Label Extension

  • Novartis CQGE031G12301

  • Novartis CQGE031G12303B Open Label Extension

  • Regeneron RAPID

  • UW HALLSTRAND

  • COUR CNP-201-5.002

  • Allakos AK002-018